HomeNews

News Search

News

Results:
Tag: FDA
Clear
  • FDA issues emergency use authorization for third COVID-19 vaccine

    Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
  • COVID-19 Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna Inc.
  • COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs

    Emergency use authorizations, or EUAs, are an important tool in our country’s fight against COVID-19 and other public health emergencies. While EUAs have received increased attention during the COVID-19 public health emergency, EUAs are not a new tool to the FDA. I want to take a moment to reaffirm FDA’s commitment to transparency around the EUA process and share some updates on our plan to provide more information about FDA’s decisions to issue, revise or revoke EUAs for drugs and biological products, including vaccines.
  • Air Force says CBD products not ok to use, may cause positive drug test

    Cannabidiol oil, also known as CBD oil, is growing in popularity as an ingredient in health and pet products, but is it okay for service members and federal employees to use? The simple answer is no.
  • Health agencies investigating severe lung illnesses linked to e-cigarette use

    The Centers for Disease Control and Prevention is working with the Food and Drug Administration, state and local health departments, and other public health partners to investigate a multistate outbreak of severe lung illnesses linked to e-cigarette use. As of Sept. 6, the CDC said, 33 states as well as the U.S. Virgin Islands have reported more than 450 possible cases of lung illnesses associated with using e-cigarette products. Six deaths have been confirmed in California, Illinois, Indiana, Kansas, Minnesota, and Oregon.
  • Voluntary Drug Recall Alert: Fentanyl

    On April 19, 2019, the Food and Drug Administration (FDA) announced a voluntary recall of a small number of cartons labeled Fentanyl 12 mcg/h Transdermal System patches. Fentanyl is used to manage pain for patients who can tolerate opioids.  
  • FDA takes additional action to mitigate shortages of EpiPen by extending expiration date for specific lots of medication

    Due to the intermittent supply interruptions of EpiPen, FDA is alerting health care professionals and patients of updated dates through which some EpiPens and the authorized generic version, manufactured by Meridian Medical Technologies, a Pfizer company, may be used beyond the manufacturer’s labeled expiration date. To help ensure patient safety,
  • First-ever blood test for detecting brain injury cleared by FDA

    You’re throwing a football around in the yard with your neighbors. While stretching out as far as you can to catch the pass, you slam your head hard against a pole going for the ball. Seeing stars and feeling confused, you take a seat. Wouldn’t it be nice if a test could say whether you have a brain injury?
  • Get Answers to Your Medication Questions

    Have you ever picked up a prescription, got home and realized you had a question? Maybe you had a headache but weren’t sure how the pain reliever would work with another medication you take? You’re not alone. “Your safety is important to us. Don’t be afraid to call and ask your doctor or pharmacist to explain prescription directions again if you
RSS